KRENSAVAGE ASSET MANAGEMENT, LLC – Enanta Pharmaceuticals, Inc. Transaction History
KRENSAVAGE ASSET MANAGEMENT, LLC portfolio value:
$30.57M
portfolio value
KRENSAVAGE ASSET MANAGEMENT, LLC quarter portfolio value change:
+9.73%
quarter
Enanta Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.67% | -35.40K shares | 1.03M | $51.87 | 589.36K |
| Q2 2022 | share | Increase | +13.84% | 75.94K shares | -9.53M | $47.27 | 624.76K |
| Q1 2022 | share | Decrease | -2.71% | -15.27K shares | -3.11M | $71.18 | 548.82K |
| Q4 2021 | share | Decrease | -39.78% | -372.67K shares | -11.03M | $74.57 | 564.10K |
| Q3 2021 | share | Decrease | -0.31% | -2.87K shares | 11.86M | $56.81 | 936.77K |
| Q2 2021 | share | Increase | +8.90% | 76.80K shares | -1.20M | $44.01 | 939.65K |
| Q1 2021 | share | Increase | +0.47% | 4.03K shares | 6.4M | $49.32 | 862.84K |
| Q4 2020 | share | Increase | +4.06% | 33.48K shares | -1.62M | $42.1 | 858.81K |
| Q3 2020 | share | Increase | +8.15% | 62.22K shares | -531K | $45.78 | 825.32K |
| Q2 2020 | share | Increase | +8.97% | 62.78K shares | 2.29M | $50.21 | 763.10K |
| Q1 2020 | share | Increase | +43.10% | 210.93K shares | 5.78M | $51.43 | 700.31K |
| Q4 2019 | share | Decrease | -1.90% | -9.48K shares | 262K | $61.78 | 489.38K |
| Q3 2019 | share | Increase | +4.02% | 19.29K shares | -10.49M | $60.08 | 498.87K |
| Q2 2019 | share | Increase | +0.74% | 3.53K shares | -5.00M | $84.38 | 479.57K |
| Q1 2019 | share | Decrease | -10.99% | -58.78K shares | 7.59M | $95.52 | 476.04K |
| Q4 2018 | share | Increase | +4.62% | 23.63K shares | -5.80M | $70.83 | 534.82K |
| Q3 2018 | share | Decrease | -1.51% | -7.84K shares | -16.47M | $85.46 | 511.18K |
| Q2 2018 | share | Decrease | -29.84% | -220.70K shares | 304K | $115.9 | 519.03K |
| Q1 2018 | share | Decrease | -14.66% | -127.03K shares | 8.99M | $80.91 | 739.73K |
| Q4 2017 | share | Decrease | -14.51% | -147.07K shares | 3.41M | $58.68 | 866.77K |
| Q3 2017 | share | Decrease | -8.25% | -91.14K shares | 7.69M | $46.8 | 1.01M |
| Q2 2017 | share | Increase | +0.59% | 6.46K shares | 5.92M | $35.98 | 1.10M |
| Q1 2017 | share | Increase | +4.05% | 42.80K shares | -1.53M | $30.8 | 1.09M |
| Q4 2016 | share | Increase | +5.60% | 55.97K shares | 8.76M | $33.5 | 1.05M |
| Q3 2016 | share | Increase | +10.23% | 92.81K shares | 6.60M | $26.61 | 999.74K |
| Q2 2016 | share | Increase | +2.76% | 24.40K shares | -5.92M | $22.05 | 906.93K |
| Q1 2016 | share | Increase | +0.46% | 4.08K shares | -3.08M | $29.37 | 882.52K |